Article
Aquaporin gene therapy corrects Sjögren’s syndrome phenotype in mice
2 May 2016
Abstract excerpt
Primary Sjögren's syndrome (pSS) is a chronic autoimmune disease that is estimated to affect 35 million people worldwide. Currently, no effective treatments exist for Sjögren's syndrome, and there is a limited understanding of the physiological mechanisms associated with xerostomia and hyposalivation. The present work revealed that aquaporin 5 expression, a water channel critical for salivary gland fluid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
